139 related articles for article (PubMed ID: 24247421)
1. Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway.
Maayah ZH; Ansari MA; El Gendy MA; Al-Arifi MN; Korashy HM
Arch Toxicol; 2014 Mar; 88(3):725-38. PubMed ID: 24247421
[TBL] [Abstract][Full Text] [Related]
2. The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model.
Ansari MA; Maayah ZH; Bakheet SA; El-Kadi AO; Korashy HM
Toxicology; 2013 Apr; 306():40-9. PubMed ID: 23391631
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.
Maayah ZH; El Gendy MA; El-Kadi AO; Korashy HM
Arch Toxicol; 2013 May; 87(5):847-56. PubMed ID: 23288144
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, β-MHC) in rat cardiomyocyte H9c2 cells.
Alsaad AMS
Toxicol Mech Methods; 2018 Nov; 28(9):678-684. PubMed ID: 29975149
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.
Korashy HM; Al-Suwayeh HA; Maayah ZH; Ansari MA; Ahmad SF; Bakheet SA
Cardiovasc Toxicol; 2015 Jan; 15(1):41-51. PubMed ID: 24984876
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
Korashy HM; Attafi IM; Ansari MA; Assiri MA; Belali OM; Ahmad SF; Al-Alallah IA; Anazi FE; Alhaider AA
Toxicol Lett; 2016 Jun; 252():50-61. PubMed ID: 27084042
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes.
Zhou B; Wang X; Li F; Wang Y; Yang L; Zhen X; Tan W
Mol Med Rep; 2017 Jul; 16(1):174-180. PubMed ID: 28498411
[TBL] [Abstract][Full Text] [Related]
8. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
Alammari AH; Gerges SH; Isse FA; El-Kadi AOS
Drug Metab Dispos; 2023 Jul; 51(7):833-843. PubMed ID: 37185150
[TBL] [Abstract][Full Text] [Related]
9. TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes.
Matsuoka-Kawano K; Yoshinari K; Nagayama S; Yamazoe Y
Chem Biol Interact; 2010 Apr; 185(1):33-41. PubMed ID: 20171196
[TBL] [Abstract][Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism.
Zordoky BN; El-Kadi AO
Toxicol In Vitro; 2010 Apr; 24(3):863-71. PubMed ID: 19969063
[TBL] [Abstract][Full Text] [Related]
11. Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro.
Hu W; Sorrentino C; Denison MS; Kolaja K; Fielden MR
Mol Pharmacol; 2007 Jun; 71(6):1475-86. PubMed ID: 17327465
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
13. A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth.
Yin XF; Chen J; Mao W; Wang YH; Chen MH
J Exp Clin Cancer Res; 2012 May; 31(1):46. PubMed ID: 22592002
[TBL] [Abstract][Full Text] [Related]
14. Effects of tryptophan photoproducts in the circadian timing system: searching for a physiological role for aryl hydrocarbon receptor.
Mukai M; Tischkau SA
Toxicol Sci; 2007 Jan; 95(1):172-81. PubMed ID: 17020875
[TBL] [Abstract][Full Text] [Related]
15. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
Braeuning A; Buchmann A
Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
[TBL] [Abstract][Full Text] [Related]
16. Brain transcriptomics in response to beta-naphthoflavone treatment in rainbow trout: the role of aryl hydrocarbon receptor signaling.
Aluru N; Vijayan MM
Aquat Toxicol; 2008 Apr; 87(1):1-12. PubMed ID: 18282621
[TBL] [Abstract][Full Text] [Related]
17. Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism.
El Gendy MA; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Nov; 249(1):55-64. PubMed ID: 20732341
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.
Wu ML; Li H; Wu DC; Wang XW; Chen XY; Kong QY; Ma JX; Gao Y; Liu J
Neurosci Lett; 2005 Aug 12-19; 384(1-2):33-7. PubMed ID: 15893423
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol.
Ciolino HP; Yeh GC
Mol Pharmacol; 1999 Oct; 56(4):760-7. PubMed ID: 10496959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
